Economy and Welfare Alan Milburn Criticizes Imbalance in Youth Spending Calls for Reform US Productivity Growth Moderates in Q4 as Labor Costs Rise Implications for Inflation and Fed Policy Iran Tensions Escalate After Trump Rejects Peace Counteroffer Strait of Hormuz Disruption Risks Grow Robert Shiller Warns Market Declines May Alter Risk Perception Creating Potential Opportunities New Dating Startups Aim to Eliminate Fake Profiles Challenge Industry Giants Robinhood Launches AI Agents for Automated Trading and Credit Card Spending BCRX Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Reaction Chicago Atlantic BDC Inc LIEN Q1 2026 Earnings Strong EPS Beat Despite Flat Stock Reaction DTG Q1 2026 Earnings EPS Falls Short of Estimates Following Operational Headwinds MSN Q1 2024 Earnings Reports Net Loss Amid Limited Operational Disclosure DIS Q1 2026 Earnings Earnings Beat Driven by Streaming Progress and Theme Parks IOBT Q1 2025 Earnings Beating Estimates While Advancing Pipeline Milestones Oyster Enterprises II Acquisition Corp Units OYSEU Holds Steady at 1031 as SPAC Units Trade in Narrow Range Oxbridge Re Holdings OXBR Edges Higher Tests Key Resistance at 104 Civeo Corporation CVEO Sees Modest Decline Amid Consolidation Ceragon Networks CRNT Gains 325 as Stock Pushes Toward Key Resistance at 30 American Battery Technology Company ABAT Slips 17 as Key Support Tested Oregon Voters Reject Gas Tax Sparking Political Fallout for Senator Jeff Merkley MTX Q1 2026 Earnings EPS Beats Estimates by 887 as Shares Edge Higher BTC Development Corp BDCI Holds Steady Near Support as Volume Remains Tepid ALLY Q1 2026 Earnings EPS Beats Estimates by 1646 Stock Edges Up MKSI Q1 2026 Earnings EPS Beat Drives 4 Stock Surge Amid Strong Operational Execution HSAI Q1 2026 Earnings Solid EPS Beat Amid Light Trading IPHA Q1 2026 Earnings Significant EPS Miss Amid Ongoing RD Focus EQBK Q1 2026 Earnings EPS Misses Estimates Yet Stock Shows Resilience CanFite Biopharma Q4 2023 Earnings Significant EPS Surprise as Biotech Focuses on Clinical Pipeline TRAW Q1 2026 Earnings NarrowerthanExpected Loss Surprises on Lower Expenses